Skip to main content
Erschienen in: Annals of Hematology 2/2012

01.02.2012 | Original Article

Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement

verfasst von: Hyojin Chae, Jihyang Lim, Myungshin Kim, Joonhong Park, Yonggoo Kim, Kyungja Han, Seok Lee, Woo Sung Min

Erschienen in: Annals of Hematology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

SET-NUP214 rearrangement is a recently recognized recurrent chromosomal translocation mostly observed in T-ALL. In order to characterize this rare entity, we performed phenotypic and genetic characterization of SET-NUP214 rearrangement through an investigation of a series of 40 consecutive samples of adult T-ALL that was selected among 229 adult ALL cases during 4 years in a single institution. Four cases (10%) of SET-NUP214 translocation were identified in our study. In all cases, diagnosis of T-ALL was established according to the World Health Organization (WHO) classification, and clonal TCR rearrangements were found. The immunophenotypic markers were indicative of the precursor nature of T lymphoblasts, and they expressed one or both of the myeloid-associated antigens (CD13, CD33). Conventional cytogenetic analysis revealed complex chromosomal aberrations in all four SET-NUP214 rearranged cases and del(12)(p13)/ETV6 was frequently involved. Array-CGH demonstrated additional genomic imbalances in addition to deletion 9q34. The genomic breakpoint sequencing identified breakpoints at SET intron 7 and NUP214 intron 17, and random nucleotide addition was found in two cases at the site of rearrangement. Our independently derived data set from a single institution confirms previous findings of SET-NUP214 rearrangement, indicates the relatively high incidence of SET-NUP214 rearrangement in adult T-ALLs, and also demonstrates comprehensive clinical, phenotypic, and genetic characteristics of this entity. Also, our report on genomic breakpoints demonstrates the homogeneity in the localization of the genomic breakpoints at 9q34. Concurrent chromosomal aberrations identified in this study should provide further areas of interest in investigation of SET-NUP214-mediated leukemogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Adriaansen HJ, Guerts van Kessel AH, Wijdenes-de Bresser JH, van Drunen-Schoenmaker E, van Dongen JJ (1990) Expression of the myeloid differentiation antigen CD33 depends on the presence of human chromosome 19 in human-mouse hybrids. Ann Hum Genet 54:115–119PubMedCrossRef Adriaansen HJ, Guerts van Kessel AH, Wijdenes-de Bresser JH, van Drunen-Schoenmaker E, van Dongen JJ (1990) Expression of the myeloid differentiation antigen CD33 depends on the presence of human chromosome 19 in human-mouse hybrids. Ann Hum Genet 54:115–119PubMedCrossRef
2.
Zurück zum Zitat Rosati R, La Starza R, Barba G, Gorello P, Pierini V, Matteucci C, Roti G, Crescenzi B, Aloisi T, Aversa F, Martelli MF, Mecucci C (2007) Cryptic chromosome 9q34 deletion generates TAF-1α/CAN and TAF-1β/CAN fusion transcripts in acute myeloid leukemia. Hematologica 92:232–235CrossRef Rosati R, La Starza R, Barba G, Gorello P, Pierini V, Matteucci C, Roti G, Crescenzi B, Aloisi T, Aversa F, Martelli MF, Mecucci C (2007) Cryptic chromosome 9q34 deletion generates TAF-1α/CAN and TAF-1β/CAN fusion transcripts in acute myeloid leukemia. Hematologica 92:232–235CrossRef
3.
Zurück zum Zitat van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Becerloo HB, van der Spek PJ, Stubbs A, Cools F, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP (2008) The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111:4668–4680PubMedCrossRef van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Becerloo HB, van der Spek PJ, Stubbs A, Cools F, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP (2008) The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111:4668–4680PubMedCrossRef
4.
Zurück zum Zitat Gorello P, La Starza R, Varasano E, Chiaretti S, Elia L, Pierini V, Barba G, Brandimarte L, Crescenzi B, Vitale A, Messina M, Grammatico S, Mancini M, Matteucci C, Bardi A, Guarini A, Martelli MF, Foà R, Mecucci C (2010) Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults. Haematologica 95:79–86PubMedCrossRef Gorello P, La Starza R, Varasano E, Chiaretti S, Elia L, Pierini V, Barba G, Brandimarte L, Crescenzi B, Vitale A, Messina M, Grammatico S, Mancini M, Matteucci C, Bardi A, Guarini A, Martelli MF, Foà R, Mecucci C (2010) Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults. Haematologica 95:79–86PubMedCrossRef
5.
Zurück zum Zitat van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257–2317PubMedCrossRef van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257–2317PubMedCrossRef
6.
Zurück zum Zitat Quentmeier H, Schneider B, Rohrs S, Romani J, Zaborski M, Macleod RA, Drexler HG (2009) SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol 2:1–5CrossRef Quentmeier H, Schneider B, Rohrs S, Romani J, Zaborski M, Macleod RA, Drexler HG (2009) SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol 2:1–5CrossRef
7.
Zurück zum Zitat Rozen S, Skaletsky HJ (2000) Primer 3 on the WWW for general users and for biologist programmers. In: Krawetz S, Mixener S (eds) Bioinformatics methods and protocols: Methods in molecular biology. Humana Press, Totowa, pp 365–386 Rozen S, Skaletsky HJ (2000) Primer 3 on the WWW for general users and for biologist programmers. In: Krawetz S, Mixener S (eds) Bioinformatics methods and protocols: Methods in molecular biology. Humana Press, Totowa, pp 365–386
8.
Zurück zum Zitat Uckun FM, Sather HN, Gaynon PS, Authur EC, Trigg ME, Tubergen DG, Nachman J, Steinherz PG, Sensel MG, Reaman GH (1997) Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood 90:28–35PubMed Uckun FM, Sather HN, Gaynon PS, Authur EC, Trigg ME, Tubergen DG, Nachman J, Steinherz PG, Sensel MG, Reaman GH (1997) Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood 90:28–35PubMed
9.
Zurück zum Zitat Kandilci A, Mientjes E, Grosveld G (2004) Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia 18:337–370PubMedCrossRef Kandilci A, Mientjes E, Grosveld G (2004) Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia 18:337–370PubMedCrossRef
10.
Zurück zum Zitat Saito S, Nouno K, Shimizu R, Yamamoto M, Nagata K (2007) Impairment of erythroid and megakaryocytic differentiation by a leukemia-associated and t(9;9)-derived fusion gene product, SET/TAF1b-CAN/NUP214. J Cell Physiol 214:322–333CrossRef Saito S, Nouno K, Shimizu R, Yamamoto M, Nagata K (2007) Impairment of erythroid and megakaryocytic differentiation by a leukemia-associated and t(9;9)-derived fusion gene product, SET/TAF1b-CAN/NUP214. J Cell Physiol 214:322–333CrossRef
11.
Zurück zum Zitat Kim J, Lee SG, Song J, Kim SJ, Rha SY, Lee KA, Park TS, Choi JR (2010) Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia. Cancer Genet Cytogenet 201:73–80PubMedCrossRef Kim J, Lee SG, Song J, Kim SJ, Rha SY, Lee KA, Park TS, Choi JR (2010) Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia. Cancer Genet Cytogenet 201:73–80PubMedCrossRef
12.
Zurück zum Zitat Adriaansen HJ, Soeting PW, Wolvers-Tettero IL, van Dongen JJ (1991) Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature. Leukemia 5:744–751PubMed Adriaansen HJ, Soeting PW, Wolvers-Tettero IL, van Dongen JJ (1991) Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature. Leukemia 5:744–751PubMed
13.
Zurück zum Zitat Caudell D, Aplan PD (2008) The role of CALM-AF10 gene fusion in acute leukemia. Leukemia 22:678–685PubMedCrossRef Caudell D, Aplan PD (2008) The role of CALM-AF10 gene fusion in acute leukemia. Leukemia 22:678–685PubMedCrossRef
14.
Zurück zum Zitat von Lindern M, Breems D, van Baals S, Adriaansen H, Grosveld G (1992) Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer 5:227–234CrossRef von Lindern M, Breems D, van Baals S, Adriaansen H, Grosveld G (1992) Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer 5:227–234CrossRef
15.
Zurück zum Zitat De Keersmaecker K, Marynen P, Cools J (2005) Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 90:1116–1127PubMed De Keersmaecker K, Marynen P, Cools J (2005) Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 90:1116–1127PubMed
16.
Zurück zum Zitat Ozbek U, Kandilci A, van Baal S, Bonten J, Boyd K, Franken P, Fodde R, Fosveld GC (2007) SET-CAN, the product of the t(9;9) in acute undifferentiated leukemia, causes expansion of early hematopoietic progenitors and hyperproliferation of stomach mucosa in transgenic mice. Am J Pathol 17:654–666CrossRef Ozbek U, Kandilci A, van Baal S, Bonten J, Boyd K, Franken P, Fodde R, Fosveld GC (2007) SET-CAN, the product of the t(9;9) in acute undifferentiated leukemia, causes expansion of early hematopoietic progenitors and hyperproliferation of stomach mucosa in transgenic mice. Am J Pathol 17:654–666CrossRef
17.
Zurück zum Zitat Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Hoglund M (1997) Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes Cancer 19:77–83PubMedCrossRef Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Hoglund M (1997) Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes Cancer 19:77–83PubMedCrossRef
18.
Zurück zum Zitat Hayette S, Thomas X, Bertrand Y, Tigaud I, Callanan M, Thiebaut A, Charrin C, Archimbaud E, Magaud JP, Rimokh R (1997) Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias. Leukemia 11:1696–1699PubMedCrossRef Hayette S, Thomas X, Bertrand Y, Tigaud I, Callanan M, Thiebaut A, Charrin C, Archimbaud E, Magaud JP, Rimokh R (1997) Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias. Leukemia 11:1696–1699PubMedCrossRef
Metadaten
Titel
Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement
verfasst von
Hyojin Chae
Jihyang Lim
Myungshin Kim
Joonhong Park
Yonggoo Kim
Kyungja Han
Seok Lee
Woo Sung Min
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 2/2012
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-011-1289-x

Weitere Artikel der Ausgabe 2/2012

Annals of Hematology 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.